ResMed Inc. vs Under Armour Inc Class A — how do they compare? ResMed Inc. trades at $197.45 (market cap $28.81B), while Under Armour Inc Class A trades at $7.18 (market cap $3.07B). The key difference: ResMed Inc. is far larger — about 9.4× Under Armour Inc Class A's market cap, and ResMed Inc. pays a 1.21% dividend while Under Armour Inc Class A pays none. Which is the better fit depends on your goals.
| RMD | UA | |
|---|---|---|
Market Cap | $28.81B | $3.07B |
Sector | Health | Consumer Cyclical |
52-Week High | $293.73 | $7.88 |
52-Week Low | $182.82 | $3.96 |
Enterprise Value | $27.99B | $4.70B |
Dividend Yield | 1.21% | — |
Trailing returns across standard periods
Latest headlines on both assets
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →Under Armour is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Built on the 'technical' performance of synthetic fabrics, the company is currently undergoing a multi-year brand evolution centered on premium product innovation, operational rigor, and a renewed focus on its North American core under the guidance of founder Kevin Plank.
Read more on UA →